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Brevibacillus massiliensis strain phRT sp. nov. is the type strain of B. massiliensis sp. nov., a new 
species within the genus Brevibacillus. This strain was isolated from the fecal flora of a woman 
suffering from morbid obesity. B. massiliensis is a Gram-positive aerobic rod-shaped bacterium. 
Here we describe the features of this organism, together with the complete genome sequence 
and annotation. The 5,051,018 bp long genome (1 chromosome but no plasmid) contains 
5,051 protein-coding and 84 RNA genes, and exhibits a G+C content of 53.1%. 
Introduction 
Brevibacillus massiliensis strain phRT (= CSUR P177 = DSM 25447) is the type strain of B. 
massiliensis sp. nov. This bacterium is a Gram-positive, spore-forming, indole negative, aerobic and motile bacillus that was isolated from the stool of a 26-year-old woman suffering from mor-bid obesity. The strain was isolated as part of a study aiming at individually cultivating all species within human feces [1]. The current approach to classification of prokaryotes, often referred to as polyphasic taxonomy, relies on a combination of phenotypic and genotypic characteristics [2]. However, as more than 3,000 bacterial genomes have been sequenced to date [3] and the cost of genomic sequencing is decreasing, we recently proposed to integrate genomic information in the description of new bacterial species [4-15]. The genus Brevibacillus (Shilda et al. 1996) was created in 1996 by reclassification of 10 Bacillus species, on the basis of 16S rDNA gene sequence analysis [16]. To date, this genus is made of 18 species [17], including B. agri, B. brevis, B. 
centrosporus, B. choshinensis, B. parabrevis, B. 
reuszeri, B. formosus, B. borstelensis, B. 
laterosporus, and B. thermoruber [16], B. invocatus [18], B. limnophilus [19], B. levickii [20], B. 
ginsengisoli [21], B. panacihumi [22], B. fluminis in [23], and B. nitrificans [24]. Members of the genus 
Brevibacillus are environmental bacteria and were mostly isolated from soil [22,25]. In addition, B. 
brevis and B. centrosporus were isolated from in-door dust in schools, day care centers for children and animal sheds [26], and fecal flora of children, respectively [27]. However, several Brevibacillus species are also frequently isolated from humans, notably in nosocomial infections, causing breast abscess, pneumonia [18], peritonitis [28] and endopthalmitis [29]. Here we present a summary classification and a set of features for B. massiliensis sp. nov. strain phRT (= CSUR P177 = DSM 25447), together with the description of the complete genomic sequenc-ing and annotation. These characteristics support the circumscription of the B. massiliensis species. 
Classification and features A stool sample was collected from a 26-year-old woman living in Marseille (France). She suffered from morbid obesity and had a body mass index of 48.2 (118.8 kg, 1.57 meter). At the time of stool sample collection she was not under medication or on a diet. The patient gave an informed and signed consent. This study and the assent proce-dure were approved by the Ethics Committee of the Institut Fédératif de Recherche IFR48, Faculty of Medicine, Marseille, France (agreement 11-017). The fecal specimen was preserved at -80°C after collection. Strain phRT (Table 1) was isolated in 2011 by aerobic cultivation on M17 agar medi-um (Oxoid, Basingstoke, England). 
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This strain exhibited a nucleotide sequence simi-larity with Brevibacillus species ranging from 94% with B. centrosporus [18] to 96% with B. reuszeri, 
B. parabrevis, B. invocatus, B. brevis, B. borstelensis [18], B. panacihumi [22], B. levickii [20], (Figure 1). This latter value was lower than the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers to delineate a new species without carrying out DNA-DNA hybridization [40]. Different growth temperatures (25, 30, 37, 45°C [Table 2]) were tested; no growth occurred at 25°C, growth occurred between 30 and 45°C, and optimal growth was observed at 37°C. Grey colo-nies were 0.8 mm to 1 mm in diameter on blood-enriched Columbia agar and Brain Heart Infusion 
(BHI) agar. Growth of the strain was tested under anaerobic and microaerophilic conditions using GENbag anaer and GENbag microaer systems, re-spectively (BioMerieux), and in the presence of air, with or without 5% CO2. Growth was obtained aerobically. A weak growth was observed with 5% CO2, but no growth occurred in microaerophilic and anaerobic conditions. Gram staining showed Gram-positive rods (Figure 2). The motility test was positive. Cell diameters ranged from 0.61 µm to 0.80 µm, with a mean diameter of 0.74 µm, and from 2.60µm to 7.30 µm long, with a mean length of 4.3µm in electron microscopy. Peritrichous flagellae were also observed (Figure 3). 
Table 1. Classification and general features of Brevibacillus massiliensis strain phRT according to the 
MIGS recommendations [42] 
MIGS ID Property Term Evidence codea 
  Domain Bacteria TAS [30]  
  Phylum Firmicutes TAS [31-33] 
  Class Bacilli TAS [34,35] 
 Current classification Order Bacillales TAS [36,37] 
  Family Paenibacillaceae TAS [34,38] 
  Genus Brevibacillus TAS [16] 
  Species Brevibacillus massiliensis IDA 
  Type strain phRT IDA 
 Gram stain positive IDA 
 Cell shape rod IDA 
 Motility motile IDA 
 Sporulation sporulating IDA 
 Temperature range mesophile IDA 
 Optimum temperature 37°C IDA 
MIGS-6.3 Salinity growth in BHI medium + 5% NaCl IDA 
MIGS-22 Oxygen requirement aerobic IDA 
 Carbon source unknown  
 Energy source unknown  
MIGS-6 Habitat human gut IDA 
MIGS-15 Biotic relationship free living IDA 
 Pathogenicity unknown  
 Biosafety level 2  
MIGS-14 Isolation human feces  
MIGS-4 Geographic location France IDA 
MIGS-5 Sample collection time January 2011 IDA 
MIGS-4.1 Latitude 43.296482 IDA 
MIGS-4.2 Longitude 5.36978 IDA 
MIGS-4.3 Depth surface IDA 
MIGS-4.4 Altitude 0 m above sea level IDA 
Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report ex-
ists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated 
sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence 
codes are from the Gene Ontology project [39]. If the evidence is IDA, then the property was directly ob-
served for a live isolate by one of the authors or an expert mentioned in the acknowledgements. 
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Figure 1. Phylogenetic tree highlighting the position of Brevibacillus massiliensis strain phRT relative to other type strains 
within the Brevibacillus genus. GenBank accession numbers are indicated in parentheses. Sequences were aligned using 
CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method within MEGA program. Num-
bers at the nodes are percentages of bootstrap values obtained by repeating the analysis 500 times to generate a majority 
consensus tree. Alicyclobacillus acidocaldarius was used as outgroup. The scale bar represents a 2% nucleotide sequence 
divergence. Strain phRT exhibited catalase and oxidase activi-ties. Using an API ZYM strip (BioMerieux, Marcy l’Etoile), positive reactions were obtained for alka-line phosphatase, cystine arylamidase, acid phos-phatase and naphtol-AS-BI-phosphohydrolase. Weak reactions were obtained for esterase, ester-ase lipase, leucine arylamidase, valine 
arylamidase, and α-chymotrypsin. Using an API Coryne strip (BioMerieux), positive reactions were obtained for pyrazinamidase and alkaline phosphatase. No sugar fermentation was observed using API 50CH (Biomerieux). 
B. massiliensis is susceptible to penicillin G, amoxi-cillin, amoxicillin + clavulanic acid, ceftriaxone, 
imipenem, erythromycin, doxycycline, rifampicin, vancomycin, ciprofloxacin, gentamicin,  nitrofurantoin and resistant to metronidazole and trimetoprim + sulfamethoxazole. By comparison with B. borstelensis, its phylogenetically-closest neighbor, B. massiliensis differed in fumarate, phenylacetate and glutamate activities [18]. By comparison with B. brevis, B.massiliensis differed in alkaline and acid phosphatase production, ni-trate reductase, esterase, esterase lipase, leucine arylamidase, cystine arylamidase and valine arylamidase production. By comparison with B. 
agri, B. massiliensis differed in oxidase production.  
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Table 2. Differential characteristics of B. massiliensis sp. nov strain ph1T, B. agri strain NRRL NRS-1219, B. 
laterosporus strain JCM 2496 and B. brevis NBRC 15304T. 
Properties B.massiliensis B.agri B.laterosporus B.brevis 
Cell diameter (µm) 0.74 0.75 na 0.50 
Oxygen requirement aerobic aerobic aerobic, facultative an-
aerobic aerobic 
Gram stain + + var + 
Salt requirement na na na - 
Motility + + + + 
Endospore formation na + + + 
Production of     
Alkaline phosphatase + na na - 
Acid phosphatase + na na - 
Catalase + + + + 
Oxidase + - na + 
Nitrate reductase - - na + 
Urease - - na - 
α-galactosidase - na na - 
β- galactosidase - na na - 
β-glucuronidase - na na - 
α -glucosidase - na na - 
N-acetyl- β -glucosamidase - na na - 
Indole - - - - 
Esterase w na na + 
Esterase lipase w na na + 
Naphthyl-AS-BI-
phosphohydrolase 
+ na na + 
Arginine arylamidase - na na na 
Arginine dihydrolase - na na - 
Glutamyl glutamic acid 
arylamidase - na na na 
Phenylalanine arylamidase - na na na 
Leucine arylamidase w na na - 
Cystine arylamidase + na na - 
Valine arylamidase w na na - 
Glycine arylamidase - na na na 
Histidine arylamidase - na na na 
Serine arylamidase - na na na 
Utilization of     
D-mannose - na na - 
Habitat human gut environment environment environment 
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Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) MS protein analysis was carried out as previously described [41]. Briefly, a pipette tip was used to pick an isolated bacterial colony from a culture agar plate and spread it as a thin film on a MTP 384 MALDI-TOF target plate (Bruker Daltonics, Germany). Twelve distinct de-posits were done for strain phRT from twelve iso-lated colonies. Each smear was overlaid with 2µL of matrix solution (saturated solution of alpha-cyano-4-hydroxycinnamic acid) in 50% acetoni-trile, 2.5% tri-fluoracetic acid, and allowed to dry for five minutes. Measurements were performed with a Microflex spectrometer (Bruker). Spectra were recorded in the positive linear mode for the mass range of 2,000 to 20,000 Da (parameter set-tings: ion source 1 (ISI), 20kV; IS2, 18.5 kV; lens, 7 kV). A spectrum was obtained after 675 shots at a variable laser power. The time of acquisition was between 30 seconds and 1 minute per spot. The twelve phRT spectra were imported into the MALDI BioTyper software (version 2.0, Bruker) and analyzed by standard pattern matching (with 
default parameter settings) against the main spec-tra of 3,769 bacteria, including spectra from nine validly published Brevibacillus species that were used as reference data in the BioTyper database (updated March 15th, 2012). The method of identi-fication includes the m/z from 3,000 to 15,000 Da. For every spectrum, 100 peaks at most were taken into account and compared with the spectra in the database. A score enabled the presumptive identi-fication and discrimination of the tested species from those in a database: a score > 2 with a vali-dated species enabled the identification at the species level; a score > 1.7 but < 2 enabled the identification at the genus level; and a score < 1.7 did not enable any identification. For strain phRT, no significance score was obtained, thus suggest-ing that our isolate was not a member of a known species. We incremented our database with the spectrum from strain phRT (Figure 4). Finally, the gel view allows us to highlight the spectra differ-ences with other of Brevibacillus genera members (Figure 5). 
 
 
Figure 2. Gram staining of B. massiliensis strain phRT 
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Figure 3. Transmission electron microscopy of B. massiliensis strain phRT, using a 
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Figure 4. Reference mass spectrum from B. massiliensis strain phRT. Spectra from 12 individual colonies were 
compared and a reference spectrum was generated. 
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Figure 5. Gel view comparing Brevibacillus massiliensis phRT spectra with other members into Brevibacillus genera 
(Brevibacillus reuszeri, Brevibacillus parabrevis, Brevibacillus laterosporus, Brevibacillus formosus, Brevibacillus 
choshinensis, Brevibacillus centrosporus, Brevibacillus brevis, Brevibacillus borstelensis, Brevibacillus agri). The Gel 
View displays the raw spectra of all loaded spectrum files arranged in a pseudo-gel like look. The x-axis records the 
m/z value. The left y-axis displays the running spectrum number originating from subsequent spectra loading. The 
peak intensity is expressed by a Gray scale scheme code. The color bar and the right y-axis indicates the relation be-
tween the color a peak is displayed with and the peak intensity in arbitrary units. 
Genome sequencing information 
Genome project history The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to other members of the Brevibacillus genus, and is part of a study of the human diges-tive flora aiming at isolating all bacterial species within human feces. It was the fifth genome of a 
Brevibacillus species and the first genome of 
Brevibacillus massiliensis sp. nov. The Genbank accession number is CAGW00000000 and consists of 132 contigs. Table 3 shows the project infor-mation and its association with MIGS version 2.0 compliance [42]. 
Growth conditions and DNA isolation 
B. massiliensis sp. nov. strain phRT, (= CSUR P177 = DSM 25447), was grown aerobically on M17 agar medium at 37°C. Five petri dishes were spread and resuspended in 3×100µl of G2 buffer (EZ1 DNA Tissue kit, Qiagen). A first mechanical lysis was performed using glass powder on a Fastprep-24 device (Sample Preparation system, MP Biomedicals, USA) during 2×20 seconds. DNA was then treated with 2.5 µg/µL (30 minutes at 37°C) 
and extracted using a BioRobot EZ 1 Advanced XL (Qiagen). The DNA was then concentrated and pu-rified on a Qiamp kit (Qiagen). The yield and the concentration was measured by the Quant-it Picogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 36.8 ng/µl. 
Growth conditions and DNA isolation 
B. massiliensis sp. nov. strain phRT, (= CSUR P177 = DSM 25447), was grown aerobically on M17 agar medium at 37°C. Five petri dishes were spread and resuspended in 3×100µl of G2 buffer (EZ1 DNA Tissue kit, Qiagen). A first mechanical lysis was performed using glass powder on a Fastprep-24 device (Sample Preparation system, MP Biomedicals, USA) during 2×20 seconds. DNA was then treated with 2.5 µg/µL (30 minutes at 37°C) and extracted using a BioRobot EZ 1 Advanced XL (Qiagen). The DNA was then concentrated and pu-rified on a Qiamp kit (Qiagen). The yield and the concentration was measured by the Quant-it Picogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 36.8 ng/µl. 
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Table 3. Project information 
MIGS ID Property Term 
MIGS-31 Finishing quality High-quality draft 
MIGS-28 Libraries used One 454 paired end 3-kb library 
MIGS-29 Sequencing platforms 454 GS FLX Titanium 
MIGS-31.2 Fold coverage 54.2× 
MIGS-30 Assemblers Newbler version 2.5.3 
MIGS-32 Gene calling method Prodigal 
 INSDC ID PRJEA82077 
 Genbank ID CAGW00000000 
 Genbank Date of Release  May 30, 2012 
 Project relevance Study of the human gut microbiome 
Genome sequencing and assembly A 3kb paired-end sequencing strategy (Roche, Meylan, France) was used. Five µg of DNA was mechanically fragmented on the Hydroshear de-vice (Digilab, Holliston, MA,USA) with an enrich-ment size at 3-4kb. The DNA fragmentation was visualized through an Agilent 2100 BioAnalyzer on a DNA labchip 7500 with an optimal size of 3.2 kb. The library was constructed according to the 454 GS FLX Titanium paired end protocol. Circu-larization and nebulization were performed and generated a pattern with an optimal at 555 bp. After PCR amplification through 17 cycles fol-lowed by double size selection, the single stranded paired-end library was then quantified on the Quant-it Ribogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 21 pg/µL. The li-brary concentration equivalence was calculated as 6.94e+07 molecules/µL. The library was stored at -20°C until further use. The 3kb paired-end library was amplified in 9 emPCR reactions at 1cpb, and in 2 emPCRs at 0.5 cpb with the GS Titanium SV emPCR Kit (Lib-L) v2 (Roche).The yield of the 2 types of paired-end emPCR reactions was 7.8% and 11.2%, respective-ly, in the quality range of 5 to 20% expected from the Roche procedure. Both libraries were loaded onto GS Titanium PicoTiterPlates (PTP Kit 70×75, Roche) and pyrosequenced with the GS Titanium Sequencing Kit XLR70 and the GS FLX Titanium sequencer (Roche).The run was performed over-night and then analyzed on the cluster through the gsRunBrowser and Newbler assembler (Roche). A total of 969,014 passed filter wells were obtained and generated 274 Mb with a length average of 286 bp. The passed filter sequences were assem-bled using Newbler with 90% identity and 40bp as overlap. The final assembly identified 31 scaf-
folds and 129 contigs (>1,500 bp) and generated a genome size of 5.05Mb, which corresponds to a coverage of 54.2× coverage. 
Genome annotation Open Reading Frames (ORFs) were predicted us-ing Prodigal [43] with default parameters but the predicted ORFs were excluded if they spanned a sequencing gap region. The predicted bacterial protein sequences were searched against the GenBank database [44] and the Clusters of Orthol-ogous Groups (COG) databases using BLASTP. The tRNAScanSE tool [45] was used to find tRNA genes, whereas ribosomal RNAs were found by using RNAmmer [46] and BLASTN against the GenBank database. Lipoprotein signal peptides and numbers of transmembrane helices were pre-dicted using SignalP [47] and TMHMM [48], re-spectively. ORFans were identified if their BLASTP 
E-value was lower than 1e-03 for alignment length greater than 80 amino acids. If alignment lengths were smaller than 80 amino acids, we used an E-value of 1e-05. Such parameter thresholds have already been used in previous works to define ORFans. To estimate the mean level of nucleotide sequence similarity at the genome level between 
B. massiliensis strain phRT, B. laterosporus strain LMG15441 (GenBank accession number AFRV00000000) and B. brevis strain NBRC100599 (GenBank accession number AP008955) and B. 
agri strain BAB-2500, we compared genomes two by two and determined the mean percentage of nucleotide sequence identity among orthologous ORFs using BLASTn. Orthologous genes were de-tected using the Proteinortho software [49]. 
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Genome properties The genome of B. massiliensis strain phRT is 5,051,018 bp long (1 chromosome but no plas-mid) with a G + C content of 53.1% (Figure 6 and Table 4). Of the 5,135 predicted genes, 5,051 were protein-coding genes, and 84 were RNAs. Three rRNA genes (one 16S rRNA, one 23S rRNA and one 5S rRNA) and 81 predicted tRNA genes were iden-
tified in the genome. A total of 3,793 genes (73.86%) were assigned a putative function. Three hundred and seventy-eight genes were identified as ORFans (7.36%). The remaining genes were annotated as hypothetical proteins. The properties and the statistics of the genome are summarized in Table 4. The distribution of genes into COGs functional categories is presented in Table 5.  
 
Figure 6. Graphical circular map of the chromosome. From the outside in, the outer two circles shows open read-
ing frames oriented in the forward (colored by COG categories) and reverse (colored by COG categories) direc-
tion, respectively. The third circle marks the rRNA gene operon (red) and tRNA genes (green). The fourth circle 
shows the G+C% content plot. The inner-most circle shows GC skew, purple indicating negative values whereas 
olive for positive values. 
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Table 4. Nucleotide content and gene count levels of the genome 
Attribute Value % of totala 
Genome size (bp) 5,051,018  
DNA coding region (bp) 4,481,706 88.72 
DNA G+C content (bp) 2,682,091 53.10 
Number of replicons 1  
Extrachromosomal elements 0  
Total genes 5,135 100 
RNA genes 84 1.63 
rRNA operons 1  
Protein-coding genes 5,051 98.36 
Genes with function prediction 4,198 81.75 
Genes assigned to COGs 3,793 73.86 
Genes with peptide signals 354 6.89 
Genes with transmembrane helices 1,277 24.86 
CRISPR repeats 0  
aThe total is based on either the size of the genome in base pairs or 
the total number of protein coding genes in the annotated genome 
Table 5 Number of genes associated with the 25 general COG functional categories 
Code Value %agea Description 
J 165 3.27 Translation 
A 0 0 RNA processing and modification 
K 405 8.0 Transcription 
L 176 3.48 Replication, recombination and repair 
B 1 0.02 Chromatin structure and dynamics 
D 33 065 Cell cycle control, mitosis and meiosis 
Y 0 0 Nuclear structure 
V 50 0.99 Defense mechanisms 
T 233 4.61 Signal transduction mechanisms 
M 181 3.58 Cell wall/membrane biogenesis 
N 60 1.19 Cell motility 
Z 0 0 Cytoskeleton 
W 0 0 Extracellular structures 
U 42 0.83 Intracellular trafficking and secretion 
O 111 2.20 Posttranslational modification, protein turnover, chaperones 
C 251 4.97 Energy production and conversion 
G 327 6.47 Carbohydrate transport and metabolism 
E 700 13.86 Amino acid transport and metabolism 
F 88 1.74 Nucleotide transport and metabolism 
H 159 3.15 Coenzyme transport and metabolism 
I 171 3.39 Lipid transport and metabolism 
P 317 6.28 Inorganic ion transport and metabolism 
Q 150 2.97 Secondary metabolites biosynthesis, transport and catabolism 
R 578 11.44 General function prediction only 
S 319 6.32 Function unknown 
- 1,258 24.91 Not in COGs 
a The total is based on the total number of protein coding genes in the annotated genome. 
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Comparison with other Brevibacillus  
species genomes Here, we compared the genome of B. massiliensis strain phRT with those of B. laterosporus strain LMG15441,B. brevis strain NBRC100599 and B. 
agri  strain BAB-2500. The draft genome of B. 
massiliensis is smaller than those of B. 
laterosporus, B.agri and B. brevis (5.05, 5.14, 5.39 and 6.29 Mb, respectively). Brevibacillus 
massiliensis has a higher G+C content than 
Brevibacillus laterosporus (53.10% vs 41.09%) and Brevibacillus brevis (53.10% vs 47.27%) but smaller than Brevibacillus agri (53.10% vs 53.5%). 
B. massiliensis has a higher gene content than B. 
laterosporus (5,051 and 4,591, respectively) but lower than B. agri and B. brevis respectively (5.457 and 5.949 respectively). In addition, B. massiliensis shared 2,077, 2,500 and 2,453 orthologous genes with B. laterosporus, B. brevis and B. agri respec-tively. The average nucleotide sequence identity ranged from 67.17 to 78.81% among Brevibacillus species, and from 67.34 to 71.14% between B. 
massiliensis and other Brevibacillus species, thus confirming its new species status (Table 6). 
Table 6. The numbers of orthologous protein shared between genomes (above diagonal)† 
 B. massiliensis B. laterosporus B. brevis B. agri 
B. massiliensis 5,051 2,077 2,500 2,453 
B. laterosporus 67.34 4,591 2,403 2,356 
B. brevis 69.36 68.38 5,949 2,779 
B. agri 71.14 67.17 78.81 5,457 
†average percentage similarity of nucleotides corresponding to orthologous protein shared 
between genomes (below diagonal) and the numbers of proteins per genome (bold) [49]. 
Conclusion On the basis of phenotypic, phylogenetic and ge-nomic analyses, we formally propose the creation of Brevibacillus massiliensis sp. nov. which current-ly contains strain phRT as its sole member; . This bacterial strain was originally isolated in Mar-seille, France. 
Description of Brevibacillus massiliensis sp. nov. 
Brevibacillus massiliensis (ma.si.li.en′sis. L. gen. masc. n. massiliensis, pertaining to Massilia, the ancient Roman name for Marseille, France, where the type strain was isolated). Colonies are grey and 0.8 mm to 1 mm in diameter on blood-enriched Columbia agar. Cells are rod-shaped with a mean diameter of 0.74 µm and a mean length of 4.3µm with electron microscopy. Optimal growth is achieved aerobically. Weak growth was observed when cultures were gown under a 5% CO2. No growth is observed in 
microaerophilic or anaerobic conditions. Growth occurs between 30 and 45°C, with optimal growth occurring at 37°C. Cells stain Gram-positive, form endospores and are motile. Cells are positive for catalase, oxidase, alkaline phosphatase, cystine arylamidase, acid phosphatase, naphtol-AS-BI-phosphohydrolase and pyrazinamidase. Asaccharolytic. Cells are susceptible to penicillin G, amoxicillin, amoxicillin + clavulanic acid, ceftri-axone, imipenem, erythromycin, doxycycline, ri-fampicin, vancomycin, ciprofloxacin, gentamicin, nitrofurantoin and resistant to metronidazole and trimethoprim/sulfamethoxazole. The G+C content of the genome is 53.1%. The 16S rRNA and ge-nome sequences are deposited in Genbank and EMBL under accession numbers JN837488 and CAGW00000000, respectively. The type strain phRT (= CSUR P177 = DSM 25447) was isolated from the fecal flora of an obese pa-tient in Marseille, France. 
Brevibacillus massiliensis sp. nov. 
12 Standards in Genomic Sciences 
Acknowledgements The authors thank Mr. Julien Paganini at Xegen Compa-ny (www.xegen.fr) for automating the genomic annota- tion process. This study was funded by the Mediterranee Infection Foundation. 
References 
1. Lagier JC, Armougom F, Million M, Hugon P, 
Pagnier I, Robert C, Bittar F, Fournous G, 
Gimenez G, Maraninchi M, et al. Microbial 
culturomics: paradigm shift in the human gut 
microbiome study. Clin Microbiol Infect 2012; 
18:1185-1193. PubMed 
2. Genome Online Database. 
http://www.genomesonline.org/cgi-
bin/GOLD/index.cgi 
3. Tindall BJ, Rossello-Mora R, Busse HJ, Ludwig W, 
Kampfer P. Notes on the characterization of pro-
karyote strains for taxonomic purposes. Int J Syst 
Evol Microbiol 2010; 60:249-266. PubMed 
http://dx.doi.org/10.1099/ijs.0.016949-0 
4. Kokcha S, Mishra AK, Lagier JC, Million M, Leroy 
Q, Raoult D, Fournier PE. Non contiguous-
finished genome sequence and description of Ba-
cillus timonensis sp. nov. Stand Genomic Sci 
2012; 6:346-355. PubMed 
http://dx.doi.org/10.4056/sigs.2776064 
5. Lagier JC, El Karkouri K, Nguyen TT, Armougom 
F, Raoult D, Fournier PE. Non-contiguous finished 
genome sequence and description of 
Anaerococcus senegalensis sp. nov. Stand Ge-
nomic Sci 2012; 6:116-125. PubMed 
http://dx.doi.org/10.4056/sigs.2415480 
6. Mishra AK, Gimenez G, Lagier JC, Robert C, 
Raoult D, Fournier PE. Non-contiguous finished 
genome sequence and description of Alistipes 
senegalensis sp. nov. Stand Genomic Sci 2012; 
6:304-314. 
http://dx.doi.org/10.4056/sigs.2625821 
7. Lagier JC, Armougom F, Mishra AK, Ngyuen TT, 
Raoult D, Fournier PE. Non-contiguous finished 
genome sequence and description of Alistipes 
timonensis sp. nov. Stand Genomic Sci 2012; 
6:315-324. PubMed 
8. Mishra AK, Lagier JC, Robert C, Raoult D, Four-
nier PE. Non-contiguous finished genome se-
quence and description of Clostridium 
senegalense sp. nov. Stand Genomic Sci 2012; 
6:386-395. PubMed 
9. Mishra AK, Lagier JC, Robert C, Raoult D, Four-
nier PE. Non-contiguous finished genome se-
quence and description of Peptoniphilus 
timonensis sp. nov. [PubMed]. Stand Genomic Sci 
2012; 7:1-11. PubMed 
http://dx.doi.org/10.4056/sigs.2956294 
10. Mishra AK, Lagier JC, Rivet R, Raoult D, Fournier 
PE. Non-contiguous finished genome sequence 
and description of Paenibacillus senegalensis sp. 
nov. Stand Genomic Sci 2012; 7:70-81. PubMed 
11. Lagier JC, Gimenez G, Robert C, Raoult D, Four-
nier PE. Non-contiguous finished genome se-
quence and description of Herbaspirillum 
massiliense sp. nov. Stand Genomic Sci 2012; 
7:200-209. PubMed 
12. Roux V, El Karkouri K, Lagier JC, Robert C, Raoult 
D. Non-contiguous finished genome sequence 
and description of Kurthia massiliensis sp. nov. 
Stand Genomic Sci 2012; 7:221-232. PubMed 
http://dx.doi.org/10.4056/sigs.3206554 
13. Kokcha S, Ramasamy D, Lagier JC, Robert C, 
Raoult D, Fournier PE. Non-contiguous finished 
genome sequence and description of 
Brevibacterium senegalense sp. nov. Stand Ge-
nomic Sci 2012; 7:233-245. PubMed 
http://dx.doi.org/10.4056/sigs.3256677 
14. Ramasamy D, Kokcha S, Lagier JC, N’Guyen TT, 
Raoult D, Fournier PE. Non-contiguous finished 
genome sequence and description of 
Aeromicrobium massilense sp. nov. Stand Ge-
nomic Sci 2012; 7:246-257. PubMed 
http://dx.doi.org/10.4056/sigs.3306717 
15. Lagier JC, Ramasamy D, Rivet R, Raoult D, Four-
nier PE. Non-contiguous finished genome se-
quence and description of Cellulomonas 
massiliensis sp. nov. Stand Genomic Sci 2012; 
7:258-270. PubMed 
http://dx.doi.org/10.4056/sigs.3316719 
16. Shida O, Takagi H, Kadowaki K, Komagata K. 
Proposal for two new genera, Brevibacillus gen. 
nov. and Aneurinibacillus gen. nov. Int J Syst 
Bacteriol 1996; 46:939-946. PubMed 
http://dx.doi.org/10.1099/00207713-46-4-939 
17. List of Prokaryotic names with Standing in No-
menclature. http://www.bacterio.cict.fr 
18. Logan NA, Forsyth G, Lebbe L, Goris J, 
Heyndrickx M, Balcaen A, Verhelst A, Falsen E, 
Ljungh A, Hansson HB, De Vos P. Polyphasic 
identification of Bacillus and Brevibacillus strains 
from clinical, dairy and industrial specimens and 
Hugon et al. 
http://standardsingenomics.org 13 
proposal of Brevibacillus invocatus sp. nov. Int J 
Syst Bacteriol 2002; 52:953-966. PubMed 
19. Goto K, Fujita R, Kato Y, Asahara M, Yokota A. 
Reclassification of Brevibacillus brevis strains 
NCIMB 13288 and DSM 6472 (=NRRL NRS-887) 
as Aneurinibacillus danicus sp. nov. and 
Brevibacillus limnophilus sp. nov. Int J Syst Evol 
Microbiol 2004; 54:419-427. PubMed 
http://dx.doi.org/10.1099/ijs.0.02906-0 
20. Allan RN, Lebbe L, Heyrman J, De Vos P, Bu-
chanan CJ, Logan NA. Brevibacillus levickii sp. 
nov. and Aneurinibacillus terranovensis sp. nov., 
two novel thermoacidophiles isolated from geo-
thermal soils of northern Victoria Land, Antarcti-
ca. Int J Syst Evol Microbiol 2005; 55:1039-1050. 
PubMed http://dx.doi.org/10.1099/ijs.0.63397-0 
21. Baek SH, Im WT, Oh WH, Lee JS, Oh HM, Lee 
ST. Brevibacillus ginsengisoli sp. nov., a denitrify-
ing bacterium isolated from soil of a ginseng field. 
Int J Syst Evol Microbiol 2006; 56:2665-2669. 
PubMed http://dx.doi.org/10.1099/ijs.0.64382-0 
22. Kim MK, Sathiyaraj S, Pulla RK, Yang DC. 
Brevibacillus panacihumi sp. nov., a beta-
glucosidase-producing bacterium. Int J Syst Evol 
Microbiol 2009; 59:1227-1231. PubMed 
http://dx.doi.org/10.1099/ijs.0.001248-0 
23. Choi MJ, Bae JY, Kim KY, Kang H, Cha CJ. 
Brevibacillus fluminis sp. nov., isolated from sed-
iment of estuarine wetland. Int J Syst Evol 
Microbiol 2010; 60:1595-1599. PubMed 
http://dx.doi.org/10.1099/ijs.0.012351-0 
24. Takebe F, Hirota K, Nodasaka Y, Yumoto I. 
Brevibacillus nitrificans sp. nov., a nitrifying bac-
terium isolated from a microbiological agent for 
enhancing microbial digestion in sewage treat-
ment tanks. Int J Syst Evol Microbiol 2012; 
62:2121-2126. PubMed 
http://dx.doi.org/10.1099/ijs.0.032342-0 
25. Sharma V, Singh PK, Midha S, Ranjan M, Korpole 
S, Patil PB. Genome Sequence of Brevibacillus 
laterosporus Strain GI-9. J Bacteriol 2012; 
194:1279. PubMed 
http://dx.doi.org/10.1128/JB.06659-11 
26. Andersson AM, Weiss N, Rainey F, Salkinoja-
Salonen MS. Dust-borne bacteria in animal sheds, 
schools and children's day care centres. J Appl 
Microbiol 1999; 86:622-634. PubMed 
http://dx.doi.org/10.1046/j.1365-
2672.1999.00706.x 
27. Lee L, Tin S, Kelley ST. Culture-independent 
analysis of bacterial diversity in a child-care fa-
cility. BMC Microbiol 2007; 7:27. PubMed 
http://dx.doi.org/10.1186/1471-2180-7-27 
28. Parvez N, Cornelius LK, Fader R. Brevibacillus 




29. Tabbara KF, Juffali F, Matossian RM. Bacillus 
laterosporus endophthalmitis. Arch Ophthalmol 
1977; 95:2187-2189. PubMed 
http://dx.doi.org/10.1001/archopht.1977.0445012
0093010 
30. Woese CR, Kandler O, Wheelis ML. Towards a 
natural system of organisms: proposal for the do-
mains Archae, Bacteria, and Eukarya. Proc Natl 
Acad Sci USA 1990; 87:4576-4579. PubMed 
http://dx.doi.org/10.1073/pnas.87.12.4576 
31. Gibbons NE, Murray RGE. Proposals Concerning 
the Higher Taxa of Bacteria. Int J Syst Bacteriol 
1978; 28:1-6. 
http://dx.doi.org/10.1099/00207713-28-1-1 
32. Garrity GM, Holt JG. The Road Map to the Man-
ual. In: Garrity GM, Boone DR, Castenholz RW 
(eds), Bergey's Manual of Systematic Bacteriolo-
gy, Second Edition, Volume 1, Springer, New 
York, 2001, p. 119-169. 
33. Murray RGE. The Higher Taxa, or, a Place for 
Everything...? In: Holt JG (ed), Bergey's Manual of 
Systematic Bacteriology, First Edition, Volume 1, 
The Williams and Wilkins Co., Baltimore, 1984, 
p. 31-34. 
34. Validation list no. 132. List of new names and 
new combinations previously effectively, but not 
validly, published. Int J Syst Evol Microbiol 2010; 
60:469-472. 
http://dx.doi.org/10.1099/ijs.0.022855-0 
35. Ludwig W, Schleifer KH, Whitman WB. Class I. 
Bacilli class nov. In: De Vos P, Garrity G, Jones D, 
Krieg NR, Ludwig W, Rainey FA, Schleifer KH, 
Whitman WB (eds), Bergey's Manual of Systemat-
ic Bacteriology, Second Edition, Volume 3, 
Springer-Verlag, New York, 2009, p. 19-20. 
36. Skerman VBD, Sneath PHA. Approved list of bac-
terial names. Int J Syst Bacteriol 1980; 30:225-
420. http://dx.doi.org/10.1099/00207713-30-1-
225 
37. Prévot AR. In: Hauderoy P, Ehringer G, Guillot G, 
Magrou. J., Prévot AR, Rosset D, Urbain A (eds), 
Dictionnaire des Bactéries Pathogènes, Second 
Edition, Masson et Cie, Paris, 1953, p. 1-692. 
Brevibacillus massiliensis sp. nov. 
14 Standards in Genomic Sciences 
38. De Vos P, Ludwig W, Schleifer KH, Whitman 
WB. Family IV. Paenibacillaceae fam. nov. In: De 
Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, 
Rainey FA, Schleifer KH, Whitman WB (eds), 
Bergey's Manual of Systematic Bacteriology, Se-
cond Edition, Volume 3, Springer-Verlag, New 
York, 2009, p. 269. 
39. Ashburner M, Ball CA, Blake JA, Botstein D, But-
ler H, Cherry JM, Davis AP, Dolinski K, Dwight 
SS, Eppig JT, et al. Gene ontology: tool for the 
unification of biology. The Gene Ontology Con-
sortium. Nat Genet 2000; 25:25-29. PubMed 
http://dx.doi.org/10.1038/75556 
40. Stackebrandt E, Ebers J. Taxonomic parameters 
revisited: tarnished gold standards. Microbiol To-
day 2006; 33:152-155. 
41. Seng P, Drancourt M, Gouriet F, La Scola B, 
Fournier PE, Rolain JM, Raoult D. Ongoing revo-
lution in bacteriology: routine identification of 
bacteria by matrix-assisted laser desorption ioni-
zation time-of-flight mass spectrometry. Clin In-
fect Dis 2009; 49:543-551. PubMed 
http://dx.doi.org/10.1086/600885 
42. Field D, Garrity G, Gray T, Morrison N, Selengut 
J, Sterk P, Tatusova T, Thomson N, Allen MJ, 
Angiuoli SV, et al. The minimum information 
about a genome sequence (MIGS) specification. 
Nat Biotechnol 2008; 26:541-547. PubMed 
http://dx.doi.org/10.1038/nbt1360 
43. Prodigal. http://prodigal.ornl.gov 
44. GenBank database. 
http://www.ncbi.nlm.nih.gov/genbank 
45. Lowe TM, Eddy SR. tRNAscan-SE: a program for 
improved detection of transfer RNA genes in ge-
nomic sequence. Nucleic Acids Res 1997; 
25:955-964. PubMed 
46. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, 
Rognes T, Ussery DW. RNAmmer: consistent and 
rapid annotation of ribosomal RNA genes. Nucle-
ic Acids Res 2007; 35:3100-3108. PubMed 
http://dx.doi.org/10.1093/nar/gkm160 
47. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. 
Improved prediction of signal peptides: SignalP 
3.0. J Mol Biol 2004; 340:783-795. PubMed 
http://dx.doi.org/10.1016/j.jmb.2004.05.028 
48. Krogh A, Larsson B, von Heijne G, Sonnhammer 
EL. Predicting transmembrane protein topology 
with a hidden Markov model: application to 
complete genomes. J Mol Biol 2001; 305:567-
580. PubMed 
http://dx.doi.org/10.1006/jmbi.2000.4315 
49. Lechner M, Findeib S, Steiner L, Marz M, Stadler 
PF, Prohaska SJ. Proteinortho: Detection of (Co-
)orthologs in large-scale analysis. BMC Bioinfor-
matics 2011; 12:124. PubMed 
http://dx.doi.org/10.1186/1471-2105-12-124 
 
